Update on the COVID-19 Vaccine Research Trends: A Bibliometric Analysis

References

• World Health Organization. Coronavirus disease 2019 (COVID-19) situation report; 2020.
   Google Scholar
• World health organization coronavirus disease (COVID-19) dashboard; 2021. Available from: https://who.sprinklr.com/. Accessed October 6, 2021.
   Google Scholar
• Leng Z, Zhu R, Hou W, et al. Transplantation of ACE2 (-) mesenchymal stem cells improves the outcome of patients with COVID-19 Pneumonia. Aging Dis. 2020;11(2):216–228. doi:10.14336/AD.2020.022832257537
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-032020029
   PubMed Web of Science ®Google Scholar
• Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. doi:10.5582/bst.2020.0104732074550
   PubMed Web of Science ®Google Scholar
• Stringhini S, Wisniak A, Piumatti G, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313–319. doi:10.1016/S0140-6736(20)31304-032534626
   PubMed Web of Science ®Google Scholar
• Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015;105(3):1809–1831. doi:10.1007/s11192-015-1645-z26594073
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa203457733301246
   PubMed Web of Science ®Google Scholar
• Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a Phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467–478. doi:10.1016/S0140-6736(20)31604-432702298
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-133306989
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa203538933378609
   PubMed Web of Science ®Google Scholar
• Hannah Ritchie EM, Rodés-Guirao L, Appel C, et al. Coronavirus Pandemic (COVID-19). Published online at OurWorldInData.org; 2020. Available from: https://ourworldindata.org/coronavirus. Accessed October 6, 2021. [Online Resource].
   Google Scholar
• Radanliev P, De Roure D, Walton R. Data mining and analysis of scientific research data records on Covid-19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic. Diabetes Metab Syndr. 2020;14(5):1121–1132. doi:10.1016/j.dsx.2020.06.06332659695
   PubMed Web of Science ®Google Scholar
• Yu Y, Li Y, Zhang Z, et al. A bibliometric analysis using VOSviewer of publications on COVID-19. Ann Transl Med. 2020;8(13):816. doi:10.21037/atm-20-423532793661
   PubMed Web of Science ®Google Scholar
• Brown A, Horton R. A planetary health perspective on COVID-19: a call for papers. Lancet. 2020;395(10230):1099. doi:10.1016/S0140-6736(20)30742-X32247382
   PubMed Web of Science ®Google Scholar
• World Health Organization. Top ten threats to global health in 2019; 2019. Available from: https://www.who.int/emergencies/ten-threats-to-global-health-in-2019. Accessed December 12, 2019.
   Google Scholar
• Fisher KA, Bloomstone SJ, Walder J, et al. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults. Ann Intern Med. 2020;173(12):964–973. doi:10.7326/M20-356932886525
   PubMed Web of Science ®Google Scholar
• Puri N, Coomes EA, Haghbayan H, et al. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vaccin Immunother. 2020;16(11):2586–2593. doi:10.1080/21645515.2020.178084632693678
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang R, Zhou Z, et al. Parental psychological distress and attitudes towards COVID-19 vaccination: a cross-sectional survey in Shenzhen, China. J Affect Disord. 2021;292:552–558. doi:10.1016/j.jad.2021.06.00334147967
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang L, Jin H, et al. Vaccination against COVID-19: a systematic review and meta-analysis of acceptability and its predictors. Prev Med. 2021;150:106694. doi:10.1016/j.ypmed.2021.10669434171345
   PubMed Web of Science ®Google Scholar
• Li J, Wang P, Tracey KJ, et al. Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines. Mol Med. 2021;27(1):49. doi:10.1186/s10020-021-00313-334022793
   PubMed Web of Science ®Google Scholar
• Dong R, Chu Z, Yu F, et al. Contriving multi-epitope subunit of vaccine for COVID-19: immunoinformatics approaches. Front Immunol. 2020;11:1784. doi:10.3389/fimmu.2020.0178432849643
   PubMed Web of Science ®Google Scholar
• Jain R, Jain A, Verma SK. Prediction of epitope based peptides for vaccine development from complete proteome of novel corona virus (SARS-COV-2) using immunoinformatics. Int J Pept Res Ther. 2021;27:1–12. doi:10.1007/s10989-021-10205-z
   Web of Science ®Google Scholar
• Amirlak L, Haddad R, Hardy JD. et al. Effectiveness of booster BCG vaccination in preventing Covid-19 infection. Hum Vaccin Immunother;2021. 1–3. doi:10.1080/21645515.2021.1956228
   Web of Science ®Google Scholar
• World Health Organization. COVID-19 vaccines. Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/covid-19-vaccines. Accessed August 20, 2021.
   Google Scholar
• Eid E, Abdullah L, Kurban M, et al. Herpes zoster emergence following mRNA COVID-19 vaccine. J Med Virol. 2021;93(9):5231–5232. doi:10.1002/jmv.2703633913545
   PubMed Web of Science ®Google Scholar
• Risma KA, Edwards KM, Hummell DS, et al. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines. J Allergy Clin Immunol. 2021;147(6):2075–2082.e2072. doi:10.1016/j.jaci.2021.04.00233857566
   PubMed Web of Science ®Google Scholar
• Troelnikov A, Perkins G, Yuson C, et al. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy. J Allergy Clin Immunol. 2021;148(1):91–95. doi:10.1016/j.jaci.2021.04.03233991580
   PubMed Web of Science ®Google Scholar
• Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2101. doi:10.1056/NEJMoa210484033835769
   PubMed Web of Science ®Google Scholar
• Drago F, Ciccarese G, Rebora A, et al. Human herpesvirus-6, −7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19. J Med Virol. 2021;93(4):1850–1851. doi:10.1002/jmv.2654932970319
   PubMed Web of Science ®Google Scholar
• Rosenblum HG, Hadler SC, Moulia D, et al. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices - United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021;70(32):1094–1099. doi:10.15585/mmwr.mm7032e434383735
   PubMed Web of Science ®Google Scholar
• Moore S, Hill EM, Tildesley MJ, et al. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021;21(6):793–802. doi:10.1016/S1473-3099(21)00143-233743847
   PubMed Web of Science ®Google Scholar
• Sandmann FG, Davies NG, Vassall A, et al. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. Lancet Infect Dis. 2021;21(7):962–974. doi:10.1016/S1473-3099(21)00079-733743846
   PubMed Web of Science ®Google Scholar
• Prem K, Liu Y, Russell TW, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020;5(5):e261–e270. doi:10.1016/S2468-2667(20)30073-632220655
   PubMed Web of Science ®Google Scholar
• Ma Y, Mishra SR, Han XK, et al. The relationship between time to a high COVID-19 response level and timing of peak daily incidence: an analysis of governments’ stringency index from 148 countries. Infect Dis Poverty. 2021;10(1):96. doi:10.1186/s40249-021-00880-x34225774
   PubMed Web of Science ®Google Scholar